The Number of Patients with Acute Myocardial Infarction Decreased and Door-to-Balloon Time Delayed in COVID-19

Background. At present, COVID-19 is sweeping the world, and all countries are actively responding. During the COVID-19 epidemic, the treatment of patients with acute myocardial infarction (AMI) may be affected. Methods. We reviewed data of patients with AMI from January 23 to April 23, 2020 (2020),...

Full description

Saved in:
Bibliographic Details
Main Authors: Tianyi Ma, Yuli Huang, Wensheng Li, Jianghua Zhong, Hui Yang, Yilei Zhou, Meijun Li, Wenhao Zhong, Yue Cao, Shijuan Lu, Yunzhao Hu
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Cardiology Research and Practice
Online Access:http://dx.doi.org/10.1155/2021/6673313
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564896290570240
author Tianyi Ma
Yuli Huang
Wensheng Li
Jianghua Zhong
Hui Yang
Yilei Zhou
Meijun Li
Wenhao Zhong
Yue Cao
Shijuan Lu
Yunzhao Hu
author_facet Tianyi Ma
Yuli Huang
Wensheng Li
Jianghua Zhong
Hui Yang
Yilei Zhou
Meijun Li
Wenhao Zhong
Yue Cao
Shijuan Lu
Yunzhao Hu
author_sort Tianyi Ma
collection DOAJ
description Background. At present, COVID-19 is sweeping the world, and all countries are actively responding. During the COVID-19 epidemic, the treatment of patients with acute myocardial infarction (AMI) may be affected. Methods. We reviewed data of patients with AMI from January 23 to April 23, 2020 (2020), and January 23 to April 23, 2019 (2019), who were admitted to two hospitals from Southern China. We collected clinical characteristics, comorbidities, treatment, prognosis, and key time segments to analyze. Results. The total number of patients that had been diagnosed with AMI in the two hospitals was 218 in 2020 and 260 in 2019. The number of AMI patients that were admitted to hospitals per day decreased in 2020. The percentage of patients with AMI who refused hospitalization in 2020 was significantly higher than that in 2019 (5.0% vs 1.5%, p=0.028). There is no statistical difference in symptoms of the first medical contact (S2FMC) time between 2020 and 2019 (p=0.552). Door-to-balloon (D2B) time of ST-elevation myocardial infarction (STEMI) patients who were treated with a primary percutaneous coronary intervention (pPCI) in 2020 was 79 (63.75–105.25) mins, while D2B time in 2019 was 57.5 (41.5–76.5) mins, which was statistically different from the two groups. Conclusions. COVID-19 had an impact on the number of AMI patients who were admitted to hospitals and the time of treatment. During the COVID-19 epidemic, the number of AMI patients that were admitted to hospitals per day was decreased, while the percentage of AMI patients that refused therapy in these two hospitals increased, and the D2B time of STEMI patients was also delayed.
format Article
id doaj-art-8647ad444f36402ba1cc3854bde5c40c
institution Kabale University
issn 2090-8016
2090-0597
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Cardiology Research and Practice
spelling doaj-art-8647ad444f36402ba1cc3854bde5c40c2025-02-03T01:09:56ZengWileyCardiology Research and Practice2090-80162090-05972021-01-01202110.1155/2021/66733136673313The Number of Patients with Acute Myocardial Infarction Decreased and Door-to-Balloon Time Delayed in COVID-19Tianyi Ma0Yuli Huang1Wensheng Li2Jianghua Zhong3Hui Yang4Yilei Zhou5Meijun Li6Wenhao Zhong7Yue Cao8Shijuan Lu9Yunzhao Hu10Department of Cardiology, Shunde Hospital, Southern Medical University, Foshan, ChinaDepartment of Cardiology, Shunde Hospital, Southern Medical University, Foshan, ChinaDepartment of Cardiology, Shunde Hospital, Southern Medical University, Foshan, ChinaDepartment of Cardiology, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou, ChinaDepartment of Cardiology, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou, ChinaDepartment of Cardiology, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou, ChinaDepartment of Cardiology, Shunde Hospital, Southern Medical University, Foshan, ChinaDepartment of Cardiology, Shunde Hospital, Southern Medical University, Foshan, ChinaDepartment of Cardiology, Shunde Hospital, Southern Medical University, Foshan, ChinaDepartment of Cardiology, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou, ChinaDepartment of Cardiology, Shunde Hospital, Southern Medical University, Foshan, ChinaBackground. At present, COVID-19 is sweeping the world, and all countries are actively responding. During the COVID-19 epidemic, the treatment of patients with acute myocardial infarction (AMI) may be affected. Methods. We reviewed data of patients with AMI from January 23 to April 23, 2020 (2020), and January 23 to April 23, 2019 (2019), who were admitted to two hospitals from Southern China. We collected clinical characteristics, comorbidities, treatment, prognosis, and key time segments to analyze. Results. The total number of patients that had been diagnosed with AMI in the two hospitals was 218 in 2020 and 260 in 2019. The number of AMI patients that were admitted to hospitals per day decreased in 2020. The percentage of patients with AMI who refused hospitalization in 2020 was significantly higher than that in 2019 (5.0% vs 1.5%, p=0.028). There is no statistical difference in symptoms of the first medical contact (S2FMC) time between 2020 and 2019 (p=0.552). Door-to-balloon (D2B) time of ST-elevation myocardial infarction (STEMI) patients who were treated with a primary percutaneous coronary intervention (pPCI) in 2020 was 79 (63.75–105.25) mins, while D2B time in 2019 was 57.5 (41.5–76.5) mins, which was statistically different from the two groups. Conclusions. COVID-19 had an impact on the number of AMI patients who were admitted to hospitals and the time of treatment. During the COVID-19 epidemic, the number of AMI patients that were admitted to hospitals per day was decreased, while the percentage of AMI patients that refused therapy in these two hospitals increased, and the D2B time of STEMI patients was also delayed.http://dx.doi.org/10.1155/2021/6673313
spellingShingle Tianyi Ma
Yuli Huang
Wensheng Li
Jianghua Zhong
Hui Yang
Yilei Zhou
Meijun Li
Wenhao Zhong
Yue Cao
Shijuan Lu
Yunzhao Hu
The Number of Patients with Acute Myocardial Infarction Decreased and Door-to-Balloon Time Delayed in COVID-19
Cardiology Research and Practice
title The Number of Patients with Acute Myocardial Infarction Decreased and Door-to-Balloon Time Delayed in COVID-19
title_full The Number of Patients with Acute Myocardial Infarction Decreased and Door-to-Balloon Time Delayed in COVID-19
title_fullStr The Number of Patients with Acute Myocardial Infarction Decreased and Door-to-Balloon Time Delayed in COVID-19
title_full_unstemmed The Number of Patients with Acute Myocardial Infarction Decreased and Door-to-Balloon Time Delayed in COVID-19
title_short The Number of Patients with Acute Myocardial Infarction Decreased and Door-to-Balloon Time Delayed in COVID-19
title_sort number of patients with acute myocardial infarction decreased and door to balloon time delayed in covid 19
url http://dx.doi.org/10.1155/2021/6673313
work_keys_str_mv AT tianyima thenumberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT yulihuang thenumberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT wenshengli thenumberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT jianghuazhong thenumberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT huiyang thenumberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT yileizhou thenumberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT meijunli thenumberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT wenhaozhong thenumberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT yuecao thenumberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT shijuanlu thenumberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT yunzhaohu thenumberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT tianyima numberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT yulihuang numberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT wenshengli numberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT jianghuazhong numberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT huiyang numberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT yileizhou numberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT meijunli numberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT wenhaozhong numberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT yuecao numberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT shijuanlu numberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19
AT yunzhaohu numberofpatientswithacutemyocardialinfarctiondecreasedanddoortoballoontimedelayedincovid19